Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue

Ticker	Company	Market Cap	Revenue	EBITDA	Earnings	EPS	Revenue Growth Y/Y	Revenue Growth 5Y	Earnings Growth Y/Y	Earnings Growth 5Y	Earnings Date
ITGR	INTEGER HOLDINGS CORP	$3.74B	$1.63B	$278.52M	$98.09M	$2.94	13.07%	5.70%	44.12%	-12.15%	2024-05-22
ARGX	ARGENX SE	$23.31B	$38.62M	-$209.00M	-$320.71M	-$5.61	270.16%	9.84%	N/A	N/A	2024-05-09
VYNE	VYNE THERAPEUTICS INC	$38.21M	$424.00k	-$28.45M	-$28.45M	-$2.78	-11.11%	-34.79%	N/A	N/A	2024-05-09
SLGL	SOL-GEL TECHNOLOGIES LTD	$22.84M	$1.55M	-$26.90M	-$27.24M	-$1.01	-59.98%	64.50%	N/A	N/A	2024-05-10
MRUS	MERUS NV	$2.74B	$43.95M	-$163.72M	-$154.94M	-$3.00	5.68%	2.75%	N/A	N/A	2024-05-07
COO	COOPER COMPANIES INC	$18.37B	$3.67B	$934.70M	$290.80M	$1.47	8.48%	7.36%	-23.10%	-4.63%	2024-05-30
ZOM	ZOMEDICA CORP	$158.75M	$25.19M	-$33.96M	-$33.64M	-$0.04	33.05%	N/A	N/A	N/A	2024-05-09
XBIO	XENETIC BIOSCIENCES INC	$6.10M	$2.54M	-$4.13M	-$4.13M	-$2.71	48.80%	N/A	N/A	N/A	2024-05-09
FUSN	FUSION PHARMACEUTICALS INC	$1.81B	$2.07M	-$85.08M	-$94.90M	-$1.45	41.55%	N/A	N/A	N/A	2024-06-14
FATE	FATE THERAPEUTICS INC	$418.78M	$63.53M	-$142.65M	-$160.93M	-$1.64	-34.03%	68.05%	N/A	N/A	2024-06-07
ACIU	AC IMMUNE SA	$238.07M	$16.82M	-$58.90M	-$61.63M	-$0.73	316.44%	20.10%	N/A	N/A	2024-06-21
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$16.23M	$97.10M	$15.80M	$11.63M	$0.49	-6.05%	N/A	81.48%	N/A
HQY	HEALTHEQUITY INC	$6.83B	$999.59M	$283.57M	$55.71M	$0.65	16.00%	28.33%	N/A	-11.54%	2024-06-21
CVRX	CVRX INC	$166.79M	$39.30M	-$38.73M	-$41.20M	-$1.99	74.89%	N/A	N/A	N/A	2024-06-04
MRKR	MARKER THERAPEUTICS INC	$36.59M	$3.31M	-$8.23M	-$8.24M	-$0.94	-5.76%	74.27%	N/A	N/A	2024-06-06
ZVRA	ZEVRA THERAPEUTICS INC	$223.86M	$27.46M	-$43.54M	-$46.05M	-$1.30	170.26%	N/A	N/A	N/A	2024-05-13
IGMS	IGM BIOSCIENCES INC	$589.63M	$2.13M	-$232.05M	-$246.42M	-$4.71	99.25%	N/A	N/A	N/A	2024-06-11
VERV	VERVE THERAPEUTICS INC	$536.00M	$11.76M	-$187.55M	-$200.07M	-$3.12	505.77%	N/A	N/A	N/A	2024-05-07
PROC	PROCAPS GROUP SA	$317.04M	$414.10M	$75.58M	$52.20M	$0.52	-4.80%	N/A	-13.33%	N/A	2024-06-28
MRK	MERCK & CO INC	$323.11B	$61.40B	$8.97B	$2.31B	$0.91	6.11%	7.35%	-82.26%	-22.24%	2024-06-03
RXST	RXSIGHT INC	$2.34B	$101.10M	-$38.28M	-$44.50M	-$1.25	75.67%	N/A	N/A	N/A
CLNN	CLENE INC	$54.45M	$654.00k	-$42.81M	-$49.50M	-$0.47	38.27%	N/A	N/A	N/A	2024-05-10
DCPH	DECIPHERA PHARMACEUTICALS INC	$2.05B	$163.36M	-$187.94M	-$194.94M	-$2.29	21.87%	N/A	N/A	N/A	2024-06-20
TRAW	TRAWS PHARMA INC	$13.49M	$226.00k	-$18.93M	-$18.95M	-$0.90	0.00%	-28.72%	N/A	N/A	2024-05-13
JANX	JANUX THERAPEUTICS INC	$3.21B	$8.08M	-$56.34M	-$58.29M	-$1.32	-6.14%	N/A	N/A	N/A	2024-06-26
NYXH	NYXOAH SA	$258.93M	$4.73M	-$41.92M	-$46.97M	-$1.68	47.25%	N/A	N/A	N/A	2024-05-14
AMS	AMERICAN SHARED HOSPITAL SERVICES	$19.37M	$21.33M	$7.28M	$610.00k	$0.10	8.00%	1.58%	-52.38%	-11.09%	2024-06-25
AGL	AGILON HEALTH INC	$1.98B	$4.32B	-$234.99M	-$262.60M	-$0.64	80.74%	55.50%	N/A	N/A	2024-05-29
AEMD	AETHLON MEDICAL INC	$3.43M	$574.25k	-$11.89M	-$12.25M	-$5.09	4,278.20%	20.67%	N/A	N/A	2024-06-26
FLGT	FULGENT GENETICS INC	$643.07M	$287.53M	-$127.63M	-$165.95M	-$5.57	-21.20%	67.10%	N/A	N/A
LH	LABORATORY CORP OF AMERICA HOLDINGS	$16.95B	$12.30B	$1.55B	$433.10M	$5.10	4.62%	1.75%	-54.34%	-10.52%	2024-05-14
WAT	WATERS CORP	$18.94B	$2.96B	$1.00B	$642.23M	$10.87	-0.52%	4.09%	-7.88%	7.11%	2024-05-23
MASI	MASIMO CORP	$7.30B	$2.05B	$186.40M	$81.50M	$1.54	0.60%	16.91%	-42.54%	-15.94%	2024-06-25
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$86.02M	$802.00k	-$69.64M	-$73.35M	-$1.91	-98.21%	N/A	N/A	N/A	2024-05-10
ITOS	ITEOS THERAPEUTICS INC	$444.81M	$12.60M	-$108.13M	-$112.64M	-$3.15	-95.29%	N/A	N/A	N/A	2024-06-11
RVMD	REVOLUTION MEDICINES INC	$6.43B	$11.58M	-$430.28M	-$436.37M	-$3.86	-67.27%	-10.50%	N/A	N/A	2024-06-20
EYPT	EYEPOINT PHARMACEUTICALS INC	$558.10M	$46.02M	-$69.00M	-$70.80M	-$1.82	11.14%	58.70%	N/A	N/A	2024-06-20
SPRB	SPRUCE BIOSCIENCES INC	$31.03M	$10.09M	-$47.14M	-$47.92M	-$1.24	N/A	N/A	N/A	N/A	2024-05-22
CSTL	CASTLE BIOSCIENCES INC	$673.89M	$250.73M	-$17.87M	-$30.80M	-$1.14	64.71%	55.20%	N/A	N/A
HCSG	HEALTHCARE SERVICES GROUP INC	$797.59M	$1.68B	$79.07M	$41.01M	$0.57	-0.18%	-3.24%	23.91%	-14.53%	2024-05-28
ALT	ALTIMMUNE INC	$521.79M	$426.00k	-$87.94M	-$88.45M	-$1.66	N/A	-47.15%	N/A	N/A	2024-05-15
TOI	ONCOLOGY INSTITUTE INC	$69.93M	$324.24M	-$55.26M	-$67.88M	-$0.92	28.42%	N/A	N/A	N/A	2024-05-14
SBFM	SUNSHINE BIOPHARMA INC	$984.58k	$24.09M	-$3.82M	-$4.51M	-$19.00	454.42%	N/A	N/A	N/A	2024-05-09
RCEL	AVITA MEDICAL INC	$228.79M	$51.57M	-$32.79M	-$35.38M	-$1.40	37.03%	N/A	N/A	N/A	2024-06-05
TMDX	TRANSMEDICS GROUP INC	$4.37B	$296.92M	$14.01M	-$10.20M	-$0.32	149.23%	81.26%	N/A	N/A	2024-05-23
TLRY	TILRAY BRANDS INC	$1.59B	$743.25M	-$186.62M	-$351.95M	-$0.44	24.65%	30.54%	N/A	N/A
SGHT	SIGHT SCIENCES INC	$289.58M	$81.50M	-$47.71M	-$54.75M	-$1.12	8.27%	N/A	N/A	N/A	2024-06-06
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$15.80M	$17.07k	-$1.53M	-$8.38M	-$0.66	1,696.32%	N/A	N/A	N/A
BGNE	BEIGENE LTD	$17.01B	$2.46B	-$812.17M	-$881.71M	-$0.65	73.65%	65.47%	N/A	N/A	2024-06-05
PRE	PRENETICS GLOBAL LTD	$70.55M	$21.74M	-$55.20M	-$62.72M	-$5.58	65.17%	18.68%	N/A	N/A
NNOX	NANO-X IMAGING LTD	$546.01M	$9.91M	-$50.96M	-$60.78M	-$1.08	15.47%	N/A	N/A	N/A	2024-05-20
SPRY	ARS PHARMACEUTICALS INC	$911.94M	$30.00k	-$54.29M	-$54.37M	-$0.57	-97.72%	N/A	N/A	N/A	2024-06-20
CALT	CALLIDITAS THERAPEUTICS AB	$599.67M	$110.93M	-$31.50M	-$42.85M	-$1.60	55.09%	N/A	N/A	N/A	2024-05-13
SERA	SERA PROGNOSTICS INC	$321.66M	$306.00k	-$34.76M	-$36.24M	-$1.16	14.18%	N/A	N/A	N/A	2024-05-08
RYTM	RHYTHM PHARMACEUTICALS INC	$2.64B	$77.43M	-$168.46M	-$184.68M	-$3.20	227.56%	N/A	N/A	N/A	2024-05-07
ZLAB	ZAI LAB LTD	$1.68B	$266.72M	-$316.88M	-$334.62M	-$3.50	24.03%	360.35%	N/A	N/A	2024-05-08
INNV	INNOVAGE HOLDING CORP	$587.09M	$720.80M	-$12.92M	-$31.56M	-$0.24	4.63%	N/A	N/A	N/A	2024-05-07
SAGE	SAGE THERAPEUTICS INC	$797.41M	$91.06M	-$501.74M	-$503.14M	-$8.39	868.87%	0.07%	N/A	N/A	2024-06-10
IFRX	INFLARX NV	$76.25M	$68.58k	-$45.72M	-$46.38M	-$0.85	N/A	N/A	N/A	N/A	2024-05-08
BFLY	BUTTERFLY NETWORK INC	$204.39M	$68.08M	-$110.58M	-$121.92M	-$0.58	-7.11%	N/A	N/A	N/A
IMCR	IMMUNOCORE HOLDINGS PLC	$3.08B	$249.43M	-$50.00M	-$55.29M	-$1.13	43.05%	53.19%	N/A	N/A	2024-05-31
VCYT	VERACYTE INC	$1.57B	$361.05M	-$45.27M	-$74.40M	-$1.02	21.76%	31.45%	N/A	N/A	2024-05-07
VRDN	VIRIDIAN THERAPEUTICS INC	$978.55M	$314.00k	-$235.32M	-$237.73M	-$5.31	-82.28%	-48.16%	N/A	N/A	2024-06-17
IMTX	IMMATICS NV	$909.22M	$58.69M	-$97.57M	-$105.43M	-$1.30	-67.37%	69.15%	N/A	N/A	2024-06-05
EDAP	EDAP TMS SA	$262.69M	$65.68M	-$21.41M	-$23.02M	-$0.62	14.52%	8.31%	N/A	N/A	2024-05-16
MREO	MEREO BIOPHARMA GROUP PLC	$434.80M	$10.00M	-$27.34M	-$29.47M	-$0.20	N/A	N/A	N/A	N/A	2024-05-23
CRNX	CRINETICS PHARMACEUTICALS INC	$3.24B	$4.01M	-$212.22M	-$214.53M	-$3.69	-15.28%	10.57%	N/A	N/A	2024-05-09
APRE	APREA THERAPEUTICS INC	$28.56M	$583.23k	-$15.50M	-$14.29M	-$3.95	N/A	N/A	N/A	N/A	2024-05-13
OCS	OCULIS HOLDING AG	$465.82M	$981.11k	-$96.77M	-$98.67M	-$3.30	7.19%	N/A	N/A	N/A
CMRX	CHIMERIX INC	$89.63M	$41.00k	-$82.60M	-$82.59M	-$0.94	-99.88%	-65.81%	N/A	N/A	2024-06-20
QSI	QUANTUM-SI INC	$260.86M	$1.08M	-$90.40M	-$95.96M	-$0.68	N/A	N/A	N/A	N/A	2024-05-09
AXGN	AXOGEN INC	$247.80M	$163.73M	-$9.93M	-$21.28M	-$0.50	13.51%	12.72%	N/A	N/A	2024-06-05
IQV	IQVIA HOLDINGS INC	$41.37B	$15.07B	$3.27B	$1.36B	$7.42	3.97%	7.43%	30.86%	43.25%
RGEN	REPLIGEN CORP	$9.39B	$607.45M	$106.35M	$14.84M	$0.28	-21.90%	23.69%	-90.73%	-10.22%	2024-05-16
LXRX	LEXICON PHARMACEUTICALS INC	$450.61M	$2.31M	-$176.77M	-$193.58M	-$0.83	1,734.13%	-45.27%	N/A	N/A
KRRO	KORRO BIO INC	$453.08M	$0.00	-$73.91M	-$81.17M	-$53.08	N/A	N/A	N/A	N/A	2024-06-11
STOK	STOKE THERAPEUTICS INC	$618.66M	$7.85M	-$114.06M	-$108.53M	-$2.41	-46.10%	N/A	N/A	N/A	2024-06-05
CASI	CASI PHARMACEUTICALS INC	$36.79M	$33.88M	-$22.29M	-$26.96M	-$2.02	-21.41%	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$1.86B	$377.71M	-$111.15M	-$132.53M	-$1.72	520.01%	N/A	N/A	N/A	2024-06-05
NEPH	NEPHROS INC	$23.09M	$14.24M	-$1.36M	-$1.58M	-$0.15	42.74%	20.15%	N/A	N/A	2024-05-09
MTEM	MOLECULAR TEMPLATES INC	$8.81M	$57.31M	$1.16M	-$8.12M	$1.80	190.10%	33.96%	-92.71%	N/A	2024-05-13
BLUE	BLUEBIRD BIO INC	$109.34M	$21.73M	-$95.08M	-$91.17M	-$0.60	322.60%	-11.27%	N/A	N/A	2024-06-14
NRBO	NEUROBO PHARMACEUTICALS INC	$18.64M	$0.00	-$12.46M	-$12.47M	-$2.46	N/A	N/A	N/A	N/A	2024-06-07
LQDA	LIQUIDIA CORP	$964.79M	$17.49M	-$69.65M	-$78.50M	-$1.21	9.75%	45.23%	N/A	N/A	2024-06-20
YMAB	Y-MABS THERAPEUTICS INC	$754.72M	$84.82M	-$24.94M	-$21.43M	-$0.49	29.96%	N/A	N/A	N/A	2024-05-07
CTKB	CYTEK BIOSCIENCES INC	$839.89M	$193.02M	-$4.41M	-$12.15M	-$0.09	17.67%	N/A	N/A	N/A	2024-06-05
ACB	AURORA CANNABIS INC	$316.00M	$199.23M	-$66.17M	-$106.90M	-$3.96	30.77%	17.87%	N/A	N/A	2024-06-12
ARVN	ARVINAS INC	$2.20B	$78.50M	-$359.70M	-$367.30M	-$6.62	-40.26%	40.53%	N/A	N/A	2024-05-29
LUNG	PULMONX CORP	$360.21M	$72.99M	-$50.29M	-$58.73M	-$1.54	27.14%	N/A	N/A	N/A	2024-05-16
CRBU	CARIBOU BIOSCIENCES INC	$345.90M	$34.48M	-$96.30M	-$102.07M	-$1.38	148.91%	N/A	N/A	N/A	2024-05-07
MOLN	MOLECULAR PARTNERS AG	$118.60M	$8.00M	-$61.83M	-$70.44M	-$2.15	-95.89%	N/A	N/A	N/A
PRPO	PRECIPIO INC	$8.55M	$15.20M	-$4.32M	-$5.85M	-$4.51	61.46%	39.62%	N/A	N/A	2024-06-14
ELMD	ELECTROMED INC	$152.31M	$51.69M	$6.01M	$3.94M	$0.47	18.03%	11.25%	88.00%	15.36%	2024-05-07
EMBC	EMBECTA CORP	$598.24M	$1.12B	$207.60M	$55.30M	$0.96	0.58%	N/A	-66.08%	N/A	2024-05-09
SILK	SILK ROAD MEDICAL INC	$818.75M	$177.13M	-$45.08M	-$55.74M	-$1.44	27.77%	38.66%	N/A	N/A	2024-06-18
ATAI	ATAI LIFE SCIENCES NV	$351.98M	$314.00k	-$35.85M	-$40.22M	-$0.25	34.76%	N/A	N/A	N/A	2024-05-07
KRYS	KRYSTAL BIOTECH INC	$4.48B	$95.95M	$65.04M	$57.16M	$1.98	N/A	N/A	N/A	N/A
HLTH	CUE HEALTH INC	$22.83M	$70.94M	-$301.91M	-$373.46M	-$2.44	-85.33%	N/A	N/A	N/A	2024-05-13
TXG	10X GENOMICS INC	$3.26B	$625.45M	-$210.40M	-$264.30M	-$2.23	16.64%	N/A	N/A	N/A	2024-06-11
ETON	ETON PHARMACEUTICALS INC	$96.33M	$32.64M	-$291.00k	-$936.00k	-$0.04	42.60%	N/A	N/A	N/A	2024-05-09

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	681	-0.10%	+4.37%	-1.88%	-19.33%	7.54x	6.05x	+14.52%	+2.50%	-31.99%	+80.65%	Strong Buy
Diagnostics & Research	66	+0.47%	-0.04%	-3.23%	+1.62%	38.56x	4.23x	-23.96%	+6.32%	+11.12%	+10.22%	Buy
Drug Manufacturers - General	17	+1.17%	+3.14%	+1.61%	+13.48%	62.48x	6.25x	+34.40%	+8.36%	+14.55%	+12.50%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.12%	+2.36%	+0.74%	-4.41%	33.38x	2.15x	+11.85%	+3.07%	+5.62%	+31.34%	Strong Buy
Healthcare Plans	12	+0.45%	-0.17%	-0.14%	-1.26%	19.76x	2.91x	+19.63%	+6.04%	+14.09%	+16.72%	Buy
Health Information Services	61	+0.60%	+0.75%	-4.68%	-22.85%	77.05x	3.26x	+6.62%	+2.09%	+5.12%	+33.92%	Buy
Medical Care Facilities	51	+1.05%	+1.79%	-2.06%	+8.37%	-8.15x	4.39x	-93.28%	+6.63%	+13.88%	+16.78%	Buy
Medical Devices	154	+0.06%	+2.77%	-1.93%	-11.52%	27.44x	3.70x	+10.37%	+5.25%	+7.81%	+19.24%	Buy
Medical Distribution	9	+0.61%	-3.39%	-4.05%	+29.02%	26.18x	109.61x	-9.15%	+3.48%	+18.94%	+10.35%	Buy
Medical Instruments & Supplies	56	+1.16%	+1.68%	-0.64%	-10.06%	57.03x	3.56x	+11.41%	+7.79%	+10.25%	+19.22%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -31.83% over the past year, underperforming other healthcare stocks by -24 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 21.72% from Cross Country Healthcare's current stock price of $16.02.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock return 10.33% over the past year, overperforming other healthcare stocks by 18 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 0.88% over the past year, overperforming other healthcare stocks by 9 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 69.66% from Corcept Therapeutics's current stock price of $23.97.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 54.69%, which is 52 percentage points higher than the healthcare sector average of 2.75%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 10.11%, which is 7 percentage points higher than the healthcare sector average of 2.75%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.72%, which is 6 percentage points higher than the healthcare sector average of 2.75%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.38% in the last day, and up 2.16% over the last week. Nrx Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 45.71% yesterday.

NRx Pharmaceuticals shares are trading higher after the company announced a statistically significant safety advantage of NRX-101 compared to the standard of care comparator in its recently completed clinical trial in patients with suicidal bipolar depression and plans to seek accelerated approval of NRX-101.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -46.65% in the past year. It has underperformed other stocks in the healthcare sector by -39 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -37.29% in the past year. It has underperformed other stocks in the healthcare sector by -29 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has gained 10.33% in the past year. It has overperformed other stocks in the healthcare sector by 18 percentage points.

Are healthcare stocks a good buy now?

48.21% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 35.62% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 38.43x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.